- Home
- TALK vs ZVRA Comparison
TALK vs ZVRA Comparison
Compare TALK & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TALK
- ZVRA
- Stock Information
- Founded
- TALK 2012
- ZVRA 2006
- Country
- TALK United States
- ZVRA United States
- Employees
- TALK N/A
- ZVRA N/A
- Industry
- TALK Medical/Nursing Services
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TALK Health Care
- ZVRA Health Care
- Exchange
- TALK Nasdaq
- ZVRA Nasdaq
- Market Cap
- TALK 480.0M
- ZVRA 433.5M
- IPO Year
- TALK N/A
- ZVRA 2015
- Fundamental
- Price
- TALK $2.56
- ZVRA $7.53
- Analyst Decision
- TALK Buy
- ZVRA Strong Buy
- Analyst Count
- TALK 5
- ZVRA 8
- Target Price
- TALK $4.38
- ZVRA $22.29
- AVG Volume (30 Days)
- TALK 2.0M
- ZVRA 519.4K
- Earning Date
- TALK 05-06-2025
- ZVRA 03-11-2025
- Dividend Yield
- TALK N/A
- ZVRA N/A
- EPS Growth
- TALK N/A
- ZVRA N/A
- EPS
- TALK 0.01
- ZVRA N/A
- Revenue
- TALK $187,593,000.00
- ZVRA $23,612,000.00
- Revenue This Year
- TALK $23.45
- ZVRA $281.10
- Revenue Next Year
- TALK $21.15
- ZVRA $97.98
- P/E Ratio
- TALK $385.88
- ZVRA N/A
- Revenue Growth
- TALK 25.02
- ZVRA N/A
- 52 Week Low
- TALK $1.60
- ZVRA $4.20
- 52 Week High
- TALK $4.36
- ZVRA $9.76
- Technical
- Relative Strength Index (RSI)
- TALK 33.56
- ZVRA 47.41
- Support Level
- TALK $2.71
- ZVRA $7.78
- Resistance Level
- TALK $2.96
- ZVRA $8.33
- Average True Range (ATR)
- TALK 0.12
- ZVRA 0.40
- MACD
- TALK -0.01
- ZVRA -0.01
- Stochastic Oscillator
- TALK 5.21
- ZVRA 45.30
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.